{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:46:29Z","timestamp":1791809189565,"version":"4.3.4"},"reference-count":253,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001704","name":"European Society of Clinical Microbiology and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.cmi.2024.05.014","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T17:08:21Z","timestamp":1721236101000},"page":"1384-1407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["European society of clinical microbiology and infectious diseases guidelines for antimicrobial stewardship in emergency departments (endorsed by European association of hospital pharmacists)"],"prefix":"10.1016","volume":"30","author":[{"given":"Teske","family":"Schoffelen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cihan","family":"Papan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Carrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Eljaaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mical","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Keuleyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Martin Quir\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Peiffer-Smadja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Palos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojana","family":"Beovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Batard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Resman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"Hulscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2024.05.014_bib1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)17907-0","article-title":"Outpatient antibiotic use in Europe and association with resistance: a cross-national database study","volume":"365","author":"Goossens","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2024.05.014_bib2","doi-asserted-by":"crossref","first-page":"e547","DOI":"10.1016\/S2542-5196(23)00127-4","article-title":"Determinants of worldwide antibiotic resistance dynamics across drug-bacterium pairs: a multivariable spatial-temporal analysis using ATLAS","volume":"7","author":"Rahbe","year":"2023","journal-title":"Lancet Planet Health"},{"key":"10.1016\/j.cmi.2024.05.014_bib3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1086\/665010","article-title":"Policy statement on antimicrobial stewardship by the society for healthcare epidemiology of America (SHEA), the infectious diseases society of America (IDSA), and the pediatric infectious diseases society (PIDS)","volume":"33","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2024.05.014_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship","volume":"44","author":"Dellit","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib5","first-page":"CD003543","article-title":"Interventions to improve antibiotic prescribing practices for hospital inpatients","volume":"2","author":"Davey","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2024.05.014_bib6","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/emermed-2014-204220","article-title":"Antimicrobial stewardship in emergency departments: a neglected topic","volume":"32","author":"Pulcini","year":"2015","journal-title":"Emerg Med J"},{"key":"10.1016\/j.cmi.2024.05.014_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.annemergmed.2012.09.002","article-title":"A call to action for antimicrobial stewardship in the emergency department: approaches and strategies","volume":"62","author":"May","year":"2013","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1017\/ice.2017.3","article-title":"Current state of antimicrobial stewardship in children\u2019s hospital emergency departments","volume":"38","author":"Mistry","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2024.05.014_bib9","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib10","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cmi.2020.11.015","article-title":"Antibiotic stewardship in the emergency department: not to be overlooked","volume":"27","author":"Paul","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.05.014_bib12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.cmi.2020.10.028","article-title":"Antimicrobial stewardship in the emergency department: characteristics and evidence for effectiveness of interventions","volume":"27","author":"May","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.05.014_bib13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cmi.2022.08.026","article-title":"Use of biomarkers to individualize antimicrobial therapy duration: a narrative review","volume":"29","author":"Scott","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.05.014_bib14","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.cmi.2021.04.021","article-title":"Diagnostic accuracy of rapid nucleic acid tests for group A streptococcal pharyngitis: systematic review and meta-analysis","volume":"27","author":"Dubois","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.05.014_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2022.114109","article-title":"Advances in nucleic acid amplification techniques (NAATs): COVID-19 point-of-care diagnostics as an example","volume":"206","author":"Kang","year":"2022","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.cmi.2024.05.014_bib16","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.cmi.2017.11.018","article-title":"Multiplex PCR system for the rapid diagnosis of respiratory virus infection: systematic review and meta-analysis","volume":"24","author":"Huang","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.05.014_bib17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1745-7599.2008.00356.x","article-title":"Blood cultures for febrile patients in the acute care setting: too quick on the draw?","volume":"20","author":"Chesnutt","year":"2008","journal-title":"J Am Acad Nurse Pract"},{"key":"10.1016\/j.cmi.2024.05.014_bib18","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/jama.2012.8262","article-title":"Does this adult patient with suspected bacteremia require blood cultures?","volume":"308","author":"Coburn","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2024.05.014_bib19","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s15010-005-5065-5","article-title":"Low rate of clinical consequences derived from results of blood cultures obtained in an internal medicine emergency department","volume":"33","author":"Ehrenstein","year":"2005","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2024.05.014_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jemermed.2016.07.003","article-title":"Best clinical practice: blood culture utility in the emergency department","volume":"51","author":"Long","year":"2016","journal-title":"J Emerg Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib21","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/cid\/ciaa039","article-title":"Does this patient need blood cultures? A scoping review of indications for blood cultures in adult nonneutropenic inpatients","volume":"71","author":"Fabre","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/jamainternmed.2015.7095","article-title":"Delayed antibiotic prescribing strategies--time to implement?","volume":"176","author":"McCullough","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib23","first-page":"688","article-title":"Is Australia ready to implement delayed prescribing in primary care? A review of the evidence","volume":"45","author":"Sargent","year":"2016","journal-title":"Aust Fam Physician"},{"key":"10.1016\/j.cmi.2024.05.014_bib24","first-page":"836","article-title":"Delayed prescriptions in primary care","volume":"53","author":"Cates","year":"2003","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.cmi.2024.05.014_bib25","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1177\/0897190015585762","article-title":"Antimicrobial stewardship in the emergency department: challenges, opportunities, and a call to action for pharmacists","volume":"29","author":"Bishop","year":"2016","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.cmi.2024.05.014_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40121-015-0084-8","article-title":"Antimicrobial stewardship in the emergency department","volume":"4","author":"Trinh","year":"2015","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.cmi.2024.05.014_bib27","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1177\/1060028017709820","article-title":"A systematic review of antimicrobial stewardship interventions in the emergency department","volume":"51","author":"Losier","year":"2017","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cmi.2024.05.014_bib28","article-title":"BundlED up: A narrative review of antimicrobial stewardship initiatives and bundles in the emergency department","volume":"7","author":"Santarossa","year":"2019","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.cmi.2024.05.014_bib29","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.emc.2018.06.012","article-title":"Antimicrobial stewardship in the emergency department","volume":"36","author":"Pulia","year":"2018","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.cmi.2024.05.014_bib30","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/cid\/cir445","article-title":"Behavior change strategies to influence antimicrobial prescribing in acute care: a systematic review","volume":"53","author":"Charani","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib31","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1086\/677637","article-title":"Multisite exploration of clinical decision making for antibiotic use by emergency medicine providers using quantitative and qualitative methods","volume":"35","author":"May","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2024.05.014_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/1742-6723.13251","article-title":"Attitudes and beliefs of Australian emergency department clinicians on antimicrobial stewardship in the emergency department: a qualitative study","author":"Goulopoulos","year":"2019","journal-title":"Emerg Med Australas"},{"key":"10.1016\/j.cmi.2024.05.014_bib33","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/QMH.0000000000000242","article-title":"Antibiotic prescribing in urgent care: implementing evidence-based medicine in a rapidly emerging health care delivery setting","volume":"29","author":"Brunisholz","year":"2020","journal-title":"Qual Manag Health Care"},{"key":"10.1016\/j.cmi.2024.05.014_bib34","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1017\/ice.2020.1245","article-title":"Systematic review of determinants influencing antibiotic prescribing for uncomplicated acute respiratory tract infections in adult patients at the emergency department","volume":"43","author":"Lim","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2024.05.014_bib35","first-page":"CD005470","article-title":"Tailored interventions to address determinants of practice","volume":"2015","author":"Baker","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2024.05.014_bib36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bmj.315.7105.418","article-title":"Personal paper. Beliefs and evidence in changing clinical practice","volume":"315","author":"Grol","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2024.05.014_bib37","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1748-5908-7-50","article-title":"Knowledge translation of research findings","volume":"7","author":"Grimshaw","year":"2012","journal-title":"Implement Sci"},{"key":"10.1016\/j.cmi.2024.05.014_bib38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1468-0009.2007.00478.x","article-title":"Planning and studying improvement in patient care: the use of theoretical perspectives","volume":"85","author":"Grol","year":"2007","journal-title":"Milbank Q"},{"key":"10.1016\/j.cmi.2024.05.014_bib39","series-title":"Planning Health promotion programs: An intervention mapping approach","isbn-type":"print","author":"Bartholomew-Eldredge","year":"2016","ISBN":"https:\/\/id.crossref.org\/isbn\/9781119035497"},{"key":"10.1016\/j.cmi.2024.05.014_bib40","series-title":"The behaviour Change wheel: A guide to designing interventions","isbn-type":"print","author":"Michie","year":"2014","ISBN":"https:\/\/id.crossref.org\/isbn\/9781912141005"},{"key":"10.1016\/j.cmi.2024.05.014_bib41","series-title":"Improving patient care: The implementation of change in health care","isbn-type":"print","author":"Wensing","year":"2020","ISBN":"https:\/\/id.crossref.org\/isbn\/9781119488606"},{"key":"10.1016\/j.cmi.2024.05.014_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/qshc.2005.017327","article-title":"Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study","volume":"16","author":"Schouten","year":"2007","journal-title":"Qual Saf Health Care"},{"key":"10.1016\/j.cmi.2024.05.014_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1748-5908-8-35","article-title":"A checklist for identifying determinants of practice: a systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice","volume":"8","author":"Flottorp","year":"2013","journal-title":"Implement Sci"},{"key":"10.1016\/j.cmi.2024.05.014_bib44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13012-015-0209-1","article-title":"A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project","volume":"10","author":"Powell","year":"2015","journal-title":"Implement Sci"},{"key":"10.1016\/j.cmi.2024.05.014_bib45","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/17437199.2015.1077155","article-title":"A taxonomy of behaviour change methods: an Intervention Mapping approach","volume":"10","author":"Kok","year":"2016","journal-title":"Health Psychol Rev"},{"key":"10.1016\/j.cmi.2024.05.014_bib47","doi-asserted-by":"crossref","DOI":"10.1186\/1748-5908-1-1","article-title":"Welcome to Implementation science","volume":"1","author":"Eccles","year":"2006","journal-title":"Implementation Sci"},{"key":"10.1016\/j.cmi.2024.05.014_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a744","article-title":"Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive","volume":"337","author":"Jaeschke","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2024.05.014_bib49","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.cmi.2024.05.014_bib50","unstructured":"Cochrane Effective Practice Organisation of Care. EPOC Resources for review authors. epoc.cochrane.org\/resources\/epoc-resources-review-authors accessed date: February 28th, 2024."},{"key":"10.1016\/j.cmi.2024.05.014_bib51","series-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2014"},{"key":"10.1016\/j.cmi.2024.05.014_bib52","author":"Sch\u00fcnemann"},{"key":"10.1016\/j.cmi.2024.05.014_bib53","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cmi.2024.05.014_bib54","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0140-6736(04)15591-8","article-title":"Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial","volume":"363","author":"Christ-Crain","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2024.05.014_bib55","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJMoa1802670","article-title":"Procalcitonin-Guided use of antibiotics for lower respiratory tract infection","volume":"379","author":"Huang","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib56","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1469-0691.2009.02709.x","article-title":"Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission--a randomized trial","volume":"15","author":"Kristoffersen","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.05.014_bib57","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1440-1843.2011.01978.x","article-title":"Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia","volume":"16","author":"Long","year":"2011","journal-title":"Respirology"},{"key":"10.1016\/j.cmi.2024.05.014_bib58","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.annemergmed.2019.02.025","article-title":"Guideline-Based clinical assessment versus procalcitonin-guided antibiotic use in pneumonia: A pragmatic randomized trial","volume":"74","author":"Montassier","year":"2019","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib59","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.2009.1297","article-title":"Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial","volume":"302","author":"Schuetz","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2024.05.014_bib60","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1164\/rccm.200512-1922OC","article-title":"Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial","volume":"174","author":"Christ-Crain","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib61","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.2147\/COPD.S104051","article-title":"Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD","volume":"11","author":"Corti","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib62","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1186\/s13054-014-0471-7","article-title":"Procalcitonin guidance for reduction of antibiotic use in patients hospitalized with severe acute exacerbations of asthma: a randomized controlled study with 12-month follow-up","volume":"18","author":"Long","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2024.05.014_bib63","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ejhf.1667","article-title":"Improve Management of acute heart failure with ProcAlCiTonin in EUrope: results of the randomized clinical trial IMPACT EU Biomarkers in Cardiology (BIC) 18","volume":"22","author":"M\u00f6ckel","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cmi.2024.05.014_bib64","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ijcard.2014.06.022","article-title":"Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial","volume":"175","author":"Schuetz","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cmi.2024.05.014_bib65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1378\/chest.06-1500","article-title":"Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy","volume":"131","author":"Stolz","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2024.05.014_bib66","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1186\/1471-2334-13-596","article-title":"Procalcitonin guided antibiotic therapy of acute exacerbations of asthma: a randomized controlled trial","volume":"13","author":"Tang","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib67","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1373\/clinchem.2019.306787","article-title":"Clinical utility of procalcitonin in the diagnosis of pneumonia","volume":"65","author":"Wussler","year":"2019","journal-title":"Clin Chem"},{"key":"10.1016\/j.cmi.2024.05.014_bib68","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1373\/jalm.2018.026955","article-title":"The use of procalcitonin as a sepsis marker in a community hospital","volume":"3","author":"De Oro","year":"2019","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib69","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cmi.2018.05.011","article-title":"Procalcitonin-guided antibiotic therapy in patients with fever in a general emergency department population: a multicentre non-inferiority randomized clinical trial (HiTEMP study)","volume":"24","author":"van der Does","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.05.014_bib70","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jinf.2014.04.009","article-title":"Procalcitonin guided antibiotic therapy in patients presenting with fever in the emergency department","volume":"69","author":"Limper","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.cmi.2024.05.014_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jemermed.2008.06.021","article-title":"C-reactive protein testing does not decrease antibiotic use for acute cough illness when compared to a clinical algorithm","volume":"41","author":"Gonzales","year":"2011","journal-title":"J Emerg Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib72","article-title":"Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care","volume":"10","author":"Smedemark","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2024.05.014_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110978","article-title":"Effect of the influenza virus rapid antigen test on a physician\u2019s decision to prescribe antibiotics and on patient length of stay in the emergency department","volume":"9","author":"Jeong","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2024.05.014_bib74","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.4269\/ajtmh.15-0269","article-title":"Use of rapid influenza testing to reduce antibiotic prescriptions among outpatients with influenza-like illness in Southern Sri Lanka","volume":"93","author":"Tillekeratne","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cmi.2024.05.014_bib75","doi-asserted-by":"crossref","first-page":"74","DOI":"10.22514\/SV111.052016.5","article-title":"The effect of the rapid antigen test for influenza on clinical practice in the emergency department: a comparison of periods before and after the 2009 H1N1 Influenza pandemic","volume":"11","author":"Jun","year":"2016","journal-title":"Signa Vitae: J Intensive Care Emerg Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib76","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/irv.12857","article-title":"Point-of-care testing for influenza in a university emergency department: a prospective study","volume":"15","author":"Perlitz","year":"2021","journal-title":"Influenza Other Respir Virus."},{"key":"10.1016\/j.cmi.2024.05.014_bib77","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ajem.2018.08.005","article-title":"Point-of-care influenza testing does not significantly shorten time to disposition among patients with an influenza-like illness","volume":"37","author":"Schechter-Perkins","year":"2019","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib78","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.diagmicrobio.2016.11.015","article-title":"Contribution of a rapid influenza diagnostic test to manage hospitalized patients with suspected influenza","volume":"87","author":"Busson","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib79","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/jmv.24279","article-title":"Impact of rapid influenza PCR testing on hospitalization and antiviral use: a retrospective cohort study","volume":"87","author":"Chu","year":"2015","journal-title":"J Med Virol"},{"key":"10.1016\/j.cmi.2024.05.014_bib80","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/infdis\/jiaa690","article-title":"Point-of-Care influenza testing impacts clinical decision, patient flow, and length of stay in hospitalized adults","volume":"226","author":"Fjelltveit","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib81","first-page":"109","article-title":"Implementation of point-of-care testing and a temporary influenza ward in a Dutch hospital","volume":"77","author":"Lankelma","year":"2019","journal-title":"Neth J Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib82","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1080\/14767058.2017.1306048","article-title":"Impact of introduction of xpert flu assay for influenza PCR testing on obstetric patients: a quality improvement project","volume":"31","author":"Linehan","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib83","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz312","article-title":"Positive impact of a point-of-care molecular influenza test in the emergency department during the 2017-2018 seasonal influenza epidemic","volume":"6","author":"Martinot","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib84","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13104-020-04986-7","article-title":"The impact of point-of-care testing for influenza A and B on patient flow and management in a medical assessment unit of a general hospital","volume":"13","author":"O\u2019Connell","year":"2020","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.cmi.2024.05.014_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146620","article-title":"Economic impact of a new rapid PCR assay for detecting influenza virus in an emergency department and hospitalized patients","volume":"11","author":"Soto","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2024.05.014_bib86","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ajem.2017.10.046","article-title":"Implementation of Alere i Influenza A & B point of care test for the diagnosis of influenza in an ED","volume":"36","author":"Trabattoni","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib87","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jhin.2018.11.010","article-title":"Implementation of influenza point-of-care testing and patient cohorting during a high-incidence season: a retrospective analysis of impact on infection prevention and control and clinical outcomes","volume":"101","author":"Youngs","year":"2019","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.cmi.2024.05.014_bib88","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12879-021-06030-w","article-title":"Differences in antibiotic and antiviral use in people with confirmed influenza: a retrospective comparison of rapid influenza PCR and multiplex respiratory virus PCR tests","volume":"21","author":"Au Yeung","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib89","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5694\/mja2.50049","article-title":"The impact of rapid molecular diagnostic testing for respiratory viruses on outcomes for emergency department patients","volume":"210","author":"Wabe","year":"2019","journal-title":"Med J Aust"},{"key":"10.1016\/j.cmi.2024.05.014_bib90","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01727-18","article-title":"Impact of rapid molecular diagnostic testing of respiratory viruses on outcomes of adults hospitalized with respiratory illness: a multicenter quasi-experimental study","volume":"57","author":"Wabe","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2024.05.014_bib91","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-030104","article-title":"Timing of respiratory virus molecular testing in emergency departments and its association with patient care outcomes: a retrospective observational study across six Australian hospitals","volume":"9","author":"Wabe","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.cmi.2024.05.014_bib92","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijid.2019.03.027","article-title":"Contribution of the FilmArray Respiratory Panel in the management of adult and pediatric patients attending the emergency room during 2015-2016 influenza epidemics: an interventional study","volume":"83","author":"Busson","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib93","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/jalm\/jfaa130","article-title":"Antimicrobial stewardship optimization in the emergency department: the effect of multiplex respiratory pathogen testing and targeted educational intervention","volume":"5","author":"Durant","year":"2020","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib94","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s10096-017-3174-6","article-title":"The rapid diagnosis of viral respiratory tract infections and its impact on antimicrobial stewardship programs","volume":"37","author":"Keske","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib95","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1017\/ice.2019.166","article-title":"Role of rapid diagnostics for viral respiratory infections in antibiotic prescribing decision in the emergency department","volume":"40","author":"Li","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2024.05.014_bib96","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1099\/jmm.0.000007","article-title":"Comparison of turnaround time and time to oseltamivir discontinuation between two respiratory viral panel testing methodologies","volume":"64","author":"Pettit","year":"2015","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.cmi.2024.05.014_bib97","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/irv.12701","article-title":"Rapid detection of respiratory organisms with FilmArray respiratory panel and its impact on clinical decisions in Shanghai, China, 2016-2018","volume":"14","author":"Qian","year":"2020","journal-title":"Influenza Other Respir Virus."},{"key":"10.1016\/j.cmi.2024.05.014_bib98","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1128\/JCM.00549-16","article-title":"Impact of early detection of respiratory viruses by multiplex PCR assay on clinical outcomes in adult patients","volume":"54","author":"Rappo","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2024.05.014_bib99","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/infdis\/jix288","article-title":"Multiplex respiratory virus testing for antimicrobial stewardship: a prospective assessment of antimicrobial use and clinical outcomes among hospitalized adults","volume":"216","author":"Semret","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jcv.2019.04.003","article-title":"More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients","volume":"116","author":"Vos","year":"2019","journal-title":"J Clin Virol"},{"key":"10.1016\/j.cmi.2024.05.014_bib101","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1186\/s12879-017-2784-z","article-title":"Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use","volume":"17","author":"Andrews","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib102","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S2213-2600(17)30120-0","article-title":"Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial","volume":"5","author":"Brendish","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib103","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jcv.2018.09.009","article-title":"Clinical impact of rapid molecular detection of respiratory pathogens in patients with acute respiratory infection","volume":"108","author":"Echavarr\u00eda","year":"2018","journal-title":"J Clin Virol"},{"key":"10.1016\/j.cmi.2024.05.014_bib104","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.diagmicrobio.2015.08.001","article-title":"The clinical impact of the detection of potential etiologic pathogens of community-acquired pneumonia","volume":"83","author":"Gelfer","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib105","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cmi.2019.09.013","article-title":"Impact of multiplex respiratory virus testing on antimicrobial consumption in adults in acute care: a randomized clinical trial","volume":"26","author":"Saarela","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.05.014_bib106","first-page":"85","article-title":"Clinical utility of a Legionella pneumophila urinary antigen test in a large university teaching hospital","volume":"14","author":"Dionne","year":"2003","journal-title":"Can J Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib107","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11739-016-1586-4","article-title":"Cost effectiveness of pneumococcal urinary antigen in Emergency Department: a pragmatic real-life study","volume":"13","author":"Dinh","year":"2018","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib108","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/thx.2009.118588","article-title":"Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia","volume":"65","author":"Falguera","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.cmi.2024.05.014_bib109","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1017\/ice.2015.202","article-title":"A randomized clinical trial comparing use of rapid molecular testing for Staphylococcus aureus for patients with cutaneous abscesses in the emergency department with standard of care","volume":"36","author":"May","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2024.05.014_bib110","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1093\/cid\/ciu039","article-title":"Introduction of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing and antibiotic selection among hospitalized patients with purulent skin infections","volume":"58","author":"Terp","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib111","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/infdis\/jiv252","article-title":"Serum procalcitonin measurement and viral testing to guide antibiotic use for respiratory infections in hospitalized adults: a randomized controlled trial","volume":"212","author":"Branche","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib112","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa057","article-title":"Low uptake of rapid diagnostic tests for respiratory tract infections in an urban safety net hospital","volume":"7","author":"Burrowes","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib113","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11739-019-02212-2","article-title":"Reduced utility of early procalcitonin and blood culture determination in patients with febrile urinary tract infections in the emergency department","volume":"15","author":"Covino","year":"2020","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib114","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12916-015-0347-y","article-title":"Procalcitonin and pyuria-based algorithm reduces antibiotic use in urinary tract infections: a randomized controlled trial","volume":"13","author":"Drozdov","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.diagmicrobio.2016.06.008","article-title":"The potential of molecular diagnostics and serum procalcitonin levels to change the antibiotic management of community-acquired pneumonia","volume":"86","author":"Gilbert","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib116","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jamda.2019.09.020","article-title":"Combining procalcitonin and rapid multiplex respiratory virus testing for antibiotic stewardship in older adult patients with severe acute respiratory infection","volume":"21","author":"Lee","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.cmi.2024.05.014_bib117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18360","volume":"18","author":"Nicholson","year":"2014","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.cmi.2024.05.014_bib118","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/jcp.2004.024356","article-title":"Antibiotic selection patterns in acutely febrile new outpatients with or without immediate testing for C reactive protein and leucocyte count","volume":"58","author":"Takemura","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.cmi.2024.05.014_bib119","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archinternmed.2012.770","article-title":"Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in \"real life\": an international, multicenter poststudy survey (ProREAL)","volume":"172","author":"Albrich","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib120","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/01.idc.0000198462.55744.f8","article-title":"Compliance of resident and staff physicians with IDSA guidelines for the diagnosis and treatment of Streptococcal pharyngitis","volume":"14","author":"Fakih","year":"2006","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.cmi.2024.05.014_bib121","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajem.2017.07.033","article-title":"Procalcitonin in the Emergency Department: a potential expensive over-request that can be modulated through institutional protocols","volume":"36","author":"Salinas","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib122","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.arbres.2012.12.008","article-title":"Improved management of community-acquired pneumonia in the emergency department","volume":"49","author":"Juli\u00e1n-Jim\u00e9nez","year":"2013","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.cmi.2024.05.014_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jemermed.2006.12.034","article-title":"Selective use of blood cultures in emergency department pneumonia patients","volume":"33","author":"Benenson","year":"2007","journal-title":"J Emerg Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib124","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s11739-016-1445-3","article-title":"Adherence to guidelines for hospitalized community-acquired pneumonia over time and its impact on health outcomes and mortality","volume":"11","author":"Costantini","year":"2016","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib125","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/archinte.161.17.2099","article-title":"Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals","volume":"161","author":"Dedier","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib126","doi-asserted-by":"crossref","first-page":"1175.e9","DOI":"10.1016\/j.amjmed.2011.05.029","article-title":"Processes of care and outcomes for community-acquired pneumonia","volume":"124","author":"Lee","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib127","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1001\/jama.1997.03550230056037","article-title":"Quality of care, process, and outcomes in elderly patients with pneumonia","volume":"278","author":"Meehan","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2024.05.014_bib128","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/intqhc\/mzt078","article-title":"Impact of guideline-concordant microbiological testing on outcomes of pneumonia","volume":"26","author":"Uematsu","year":"2014","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.cmi.2024.05.014_bib129","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jhm.382","article-title":"Blood cultures for community-acquired pneumonia: are they worthy of two quality measures? A systematic review","volume":"4","author":"Afshar","year":"2009","journal-title":"J Hosp Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib130","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1164\/rccm.200309-1248OC","article-title":"Predicting bacteremia in patients with community-acquired pneumonia","volume":"169","author":"Metersky","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib131","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1378\/chest.108.4.932","article-title":"Clinical utility of blood cultures in adult patients with community-acquired pneumonia without defined underlying risks","volume":"108","author":"Chalasani","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2024.05.014_bib132","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1183\/09031936.00152514","article-title":"Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis","volume":"45","author":"Torres","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2024.05.014_bib133","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005058","article-title":"Predictive factors of true bacteremia and the clinical utility of blood cultures as a prognostic tool in patients with community-onset pneumonia","volume":"95","author":"Lee","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cmi.2024.05.014_bib134","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/rmed.2000.0977","article-title":"The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures","volume":"95","author":"Waterer","year":"2001","journal-title":"Respir Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib135","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.amjmed.2019.03.025","article-title":"Utility of blood cultures in pneumonia","volume":"132","author":"Zhang","year":"2019","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib136","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1378\/chest.123.4.1142","article-title":"The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia: a prospective observational study","volume":"123","author":"Campbell","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2024.05.014_bib137","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/106286069801300405","article-title":"Effects of timely antibiotic administration and culture acquisition on the treatment of urinary tract infection","volume":"13","author":"Hood","year":"1998","journal-title":"Am J Med Qual"},{"key":"10.1016\/j.cmi.2024.05.014_bib138","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1128\/JCM.00425-10","article-title":"Should blood cultures be performed for patients with acute prostatitis?","volume":"48","author":"Etienne","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2024.05.014_bib139","first-page":"50","article-title":"Bacteremia in young urban women admitted with pyelonephritis","volume":"313","author":"Smith","year":"1997","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cmi.2024.05.014_bib140","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10096-007-0287-3","article-title":"Prevalence and predictive features of bacteremic urinary tract infection in emergency department patients","volume":"26","author":"Bahagon","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib141","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11739-016-1576-6","article-title":"Risk factors for bacteremia in urinary tract infections attended in the emergency department","volume":"13","author":"Lalueza","year":"2018","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib142","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/cid\/ciy1054","article-title":"Seven versus 14 Days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial","volume":"69","author":"Yahav","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib143","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.cmi.2021.09.001","article-title":"Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial","volume":"28","author":"Molina","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.05.014_bib144","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1080\/23744235.2018.1447682","article-title":"Blood culture useful only in selected patients with urinary tract infections - a literature review","volume":"50","author":"Karakonstantis","year":"2018","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.cmi.2024.05.014_bib145","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/cid\/ciaa811","article-title":"Does this patient with urinary tract infection need blood culture?","volume":"72","author":"Karakonstantis","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib146","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.annemergmed.2005.03.003","article-title":"Are blood cultures necessary in adults with pyelonephritis?","volume":"46","author":"Mills","year":"2005","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib147","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/378291","article-title":"Blood cultures for women with uncomplicated acute pyelonephritis: are they necessary?","volume":"37","author":"Velasco","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib148","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jinf.2005.12.005","article-title":"Are blood cultures necessary in the management of women with complicated pyelonephritis?","volume":"53","author":"Chen","year":"2006","journal-title":"J Infect"},{"key":"10.1016\/j.cmi.2024.05.014_bib149","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s11739-015-1223-7","article-title":"Relevance of blood cultures in acute pyelonephritis in a single-center retrospective study","volume":"10","author":"Ledochowski","year":"2015","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib150","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1086\/652657","article-title":"Risk factors for bacteremia with uropathogen not cultured from urine in adults with febrile urinary tract infection","volume":"50","author":"van Nieuwkoop","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib151","doi-asserted-by":"crossref","first-page":"O476","DOI":"10.1111\/1469-0691.12491","article-title":"The additional value of blood cultures in patients with complicated urinary tract infections","volume":"20","author":"Spoorenberg","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.05.014_bib152","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejim.2016.07.029","article-title":"Blood cultures in the evaluation of uncomplicated cellulitis","volume":"36","author":"Bauer","year":"2016","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib153","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204036","article-title":"Cellulitis in adult patients: a large, multicenter, observational, prospective study of 606 episodes and analysis of the factors related to the response to treatment","volume":"13","author":"Collazos","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2024.05.014_bib154","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10096-019-03490-6","article-title":"Adherence to antibiotic guidelines for erysipelas or cellulitis is associated with a favorable outcome","volume":"38","author":"Klotz","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib155","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1086\/313525","article-title":"Cost-effectiveness of blood cultures for adult patients with cellulitis","volume":"29","author":"Perl","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib156","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s10096-017-3001-0","article-title":"Clinical condition and comorbidity as determinants for blood culture positivity in patients with skin and soft-tissue infections","volume":"36","author":"van Daalen","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib157","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10096-006-0186-z","article-title":"Risk factors for bacteremia in patients with limb cellulitis","volume":"25","author":"Peralta","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib158","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.annemergmed.2004.11.006","article-title":"Are blood cultures necessary in adults with cellulitis?","volume":"45","author":"Mills","year":"2005","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib159","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2753.2010.01594.x","article-title":"Impact of postgraduate education on physician practice for community-acquired pneumonia","volume":"18","author":"Ikai","year":"2012","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.cmi.2024.05.014_bib160","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.ajem.2017.10.005","article-title":"Impact of bacteremia prediction rule in CAP: before and after study","volume":"36","author":"Kim","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib161","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/jamainternmed.2013.13808","article-title":"Blood culture use in the emergency department in patients hospitalized for community-acquired pneumonia","volume":"174","author":"Makam","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib162","first-page":"21","article-title":"Blood cultures in ambulatory patients who are discharged from emergency with community-acquired pneumonia","volume":"15","author":"Marrie","year":"2004","journal-title":"Can J Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib163","first-page":"224","article-title":"Automated dispensing cabinet alert improves compliance with obtaining blood cultures before antibiotic administration for patients admitted with pneumonia","volume":"38","author":"Sikka","year":"2012","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"10.1016\/j.cmi.2024.05.014_bib164","doi-asserted-by":"crossref","first-page":"881","DOI":"10.7326\/0003-4819-143-12-200512200-00006","article-title":"Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial","volume":"143","author":"Yealy","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib165","first-page":"119","article-title":"Erythromycin in the treatment of acute bronchitis in a community practice","volume":"23","author":"Brickfield","year":"1986","journal-title":"J Fam Pract"},{"key":"10.1016\/j.cmi.2024.05.014_bib166","first-page":"200","article-title":"A randomised controlled trial of delayed antibiotic prescribing as a strategy for managing uncomplicated\u00a0respiratory tract infection in primary care","volume":"51","author":"Dowell","year":"2001","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.cmi.2024.05.014_bib167","first-page":"137","article-title":"A placebo-controlled, double-blind trial of erythromycin in adults with acute bronchitis","volume":"25","author":"Dunlay","year":"1987","journal-title":"J Fam Pract"},{"key":"10.1016\/j.cmi.2024.05.014_bib168","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/S0140-6736(02)08597-5","article-title":"Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial","volume":"359","author":"Evans","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2024.05.014_bib169","first-page":"185","article-title":"The treatment of acute bronchitis with trimethoprim and sulfamethoxazole","volume":"19","author":"Franks","year":"1984","journal-title":"J Fam Pract"},{"key":"10.1016\/j.cmi.2024.05.014_bib170","first-page":"601","article-title":"Effectiveness of erythromycin in the treatment of acute bronchitis","volume":"42","author":"King","year":"1996","journal-title":"J Fam Pract"},{"key":"10.1016\/j.cmi.2024.05.014_bib171","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1001\/jama.293.24.3029","article-title":"Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection: a randomized controlled trial","volume":"293","author":"Little","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2024.05.014_bib172","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1473-3099(12)70300-6","article-title":"Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial","volume":"13","author":"Little","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib173","article-title":"Antibiotic prescription strategies and adverse outcome for uncomplicated lower respiratory tract infections: prospective cough complication cohort (3C) study","volume":"357","author":"Little","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2024.05.014_bib174","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f5762","article-title":"Efficacy of anti-inflammatory or antibiotic treatment in patients with non-complicated acute bronchitis and discoloured sputum: randomised placebo controlled trial","volume":"347","author":"Llor","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2024.05.014_bib175","first-page":"700","article-title":"Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol","volume":"50","author":"Matthys","year":"2000","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.cmi.2024.05.014_bib176","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/thx.2008.097311","article-title":"Placebo found equivalent to amoxicillin for treatment of acute bronchitis in Nairobi, Kenya: a triple blind, randomised, equivalence trial","volume":"63","author":"Nduba","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.cmi.2024.05.014_bib177","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/bmj.2.6035.556","article-title":"Randomised controlled trial of antibiotics in patients with cough and purulent sputum","volume":"2","author":"Stott","year":"1976","journal-title":"Br Med J"},{"key":"10.1016\/j.cmi.2024.05.014_bib178","first-page":"400","article-title":"Effects of doxycycline in patients with acute cough and purulent sputum: a double blind placebo controlled trial","volume":"44","author":"Verheij","year":"1994","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.cmi.2024.05.014_bib179","first-page":"481","article-title":"A randomized, controlled trial of doxycycline in the treatment of acute bronchitis","volume":"19","author":"Williamson","year":"1984","journal-title":"J Fam Pract"},{"key":"10.1016\/j.cmi.2024.05.014_bib180","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease","volume":"106","author":"Anthonisen","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib181","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(60)90056-8","article-title":"Exacerbations of chronic bronchitis treatment with oxytetracycline","volume":"1","author":"Berry","year":"1960","journal-title":"Lancet."},{"key":"10.1016\/j.cmi.2024.05.014_bib182","article-title":"Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbations","volume":"1","author":"Brusse-Keizer","year":"2014","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.cmi.2024.05.014_bib183","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1164\/rccm.200906-0837OC","article-title":"Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease","volume":"181","author":"Daniels","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib184","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1136\/bmj.2.5056.1272","article-title":"Prophylactic use of oxytetracycline for exacerbations of chronic bronchitis","volume":"2","author":"Elmes","year":"1957","journal-title":"Br Med J"},{"key":"10.1016\/j.cmi.2024.05.014_bib185","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ejcdt.2015.03.007","article-title":"Impact of antibiotics on acute exacerbations of COPD","volume":"64","author":"Hassan","year":"2015","journal-title":"Egypt J Chest Dis Tuberculosis"},{"key":"10.1016\/j.cmi.2024.05.014_bib186","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/02813439209014027","article-title":"Amoxicillin in treatment of acute uncomplicated exacerbations of chronic bronchitis. A double-blind, placebo-controlled multicentre study in general practice","volume":"10","author":"J\u00f8rgensen","year":"1992","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.cmi.2024.05.014_bib187","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1164\/rccm.201206-0996OC","article-title":"Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease","volume":"186","author":"Llor","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib188","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0140-6736(87)92411-1","article-title":"Antibiotics for exacerbations of chronic bronchitis","volume":"2","author":"Manresa","year":"1987","journal-title":"Lancet."},{"key":"10.1016\/j.cmi.2024.05.014_bib189","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.0954-6820.1967.tb11527.x","article-title":"A controlled study of the effect of treatment on chronic bronchitis. An evaluation using pulmonary function tests","volume":"182","author":"Petersen","year":"1967","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.cmi.2024.05.014_bib190","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0007-0971(72)90016-2","article-title":"Antibiotic regimens in moderately ill patients with purulent exacerbations of chronic bronchitis","volume":"66","author":"Pines","year":"1972","journal-title":"Br J Dis Chest"},{"key":"10.1016\/j.cmi.2024.05.014_bib191","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/thx.2008.095349","article-title":"Antibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: an historical population based cohort study","volume":"63","author":"Roede","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.cmi.2024.05.014_bib192","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1183\/09031936.00088108","article-title":"Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD","volume":"33","author":"Roede","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2024.05.014_bib193","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/thx.50.7.758","article-title":"Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice","volume":"50","author":"Sachs","year":"1995","journal-title":"Thorax"},{"key":"10.1016\/j.cmi.2024.05.014_bib194","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S2213-2600(17)30165-0","article-title":"Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial","volume":"5","author":"van Velzen","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib195","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijid.2016.04.024","article-title":"Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial","volume":"48","author":"Wang","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib196","article-title":"Global strategy for prevention","year":"2021","journal-title":"Diagn Manage COPD: 2021 Rep"},{"key":"10.1016\/j.cmi.2024.05.014_bib197","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1378\/chest.08-1680","article-title":"Definitions of exacerbations: does it really matter in clinical trials on COPD?","volume":"136","author":"Effing","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2024.05.014_bib198","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2165\/00003495-199100424-00005","article-title":"Single dose oral administration of cefixime 400mg in the treatment of acute uncomplicated cystitis and gonorrhoea","volume":"42","author":"Asbach","year":"1991","journal-title":"Drugs"},{"key":"10.1016\/j.cmi.2024.05.014_bib199","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1741-7015-8-30","article-title":"Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection?--results of a randomized controlled pilot trial","volume":"8","author":"Bleidorn","year":"2010","journal-title":"BMC Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib200","article-title":"Recurrent urinary tract infections and complications after symptomatic versus antibiotic treatment: follow-up of a randomised controlled trial","volume":"14","author":"Bleidorn","year":"2016","journal-title":"Ger Med Sci"},{"key":"10.1016\/j.cmi.2024.05.014_bib201","first-page":"729","article-title":"Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women","volume":"52","author":"Christiaens","year":"2002","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.cmi.2024.05.014_bib202","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/00365540410019642","article-title":"The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study","volume":"36","author":"Ferry","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib203","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/02813430601183074","article-title":"Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project","volume":"25","author":"Ferry","year":"2007","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.cmi.2024.05.014_bib204","article-title":"Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial","volume":"351","author":"G\u00e1gyor","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2024.05.014_bib205","first-page":"734","article-title":"Role of symptomatic treatment in comparison to antibiotics in uncomplicated urinary tract infections","volume":"28","author":"Jamil","year":"2016","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"10.1016\/j.cmi.2024.05.014_bib206","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/23744235.2020.1834138","article-title":"Uncomplicated urinary tract infection in primary health care: presentation and clinical outcome","volume":"53","author":"Kornf\u00e4lt Isberg","year":"2021","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.cmi.2024.05.014_bib207","article-title":"Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial","volume":"359","author":"Kronenberg","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2024.05.014_bib208","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c199","article-title":"Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial","volume":"340","author":"Little","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2024.05.014_bib209","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b5633","article-title":"Presentation, pattern, and natural course of severe symptoms, and role of antibiotics and antibiotic resistance among patients presenting with suspected uncomplicated urinary tract infection in primary care: observational study","volume":"340","author":"Little","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2024.05.014_bib210","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cmi.2019.01.011","article-title":"Uva-ursi extract and ibuprofen as alternative treatments for uncomplicated urinary tract infection in women (ATAFUTI): a factorial randomized trial","volume":"25","author":"Moore","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.05.014_bib211","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003336","article-title":"Antibiotic prescribing for lower UTI in elderly patients in primary care and risk of bloodstream infection: a cohort study using electronic health records in England","volume":"17","author":"Shallcross","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib212","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002569","article-title":"Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women-A double-blind, randomized non-inferiority trial","volume":"15","author":"Vik","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib213","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s11606-020-05745-x","article-title":"Is non-steroidal anti-inflammatory therapy non-inferior to antibiotic therapy in uncomplicated urinary tract infections: a systematic review","volume":"35","author":"Carey","year":"2020","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib214","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.cmi.2022.06.017","article-title":"Reducing antibiotic use in uncomplicated urinary tract infections in adult women: a systematic review and individual participant data meta-analysis","volume":"28","author":"Kau\u00dfner","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.05.014_bib215","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/codi.13355","article-title":"Management of acute uncomplicated diverticulitis without antibiotics: a single-centre cohort study","volume":"18","author":"Brochmann","year":"2016","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib216","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/bjs.8688","article-title":"Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis","volume":"99","author":"Chabok","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.cmi.2024.05.014_bib217","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/bjs.11239","article-title":"Long-term follow-up of the AVOD randomized trial of antibiotic avoidance in uncomplicated diverticulitis","volume":"106","author":"Isacson","year":"2019","journal-title":"Br J Surg"},{"key":"10.1016\/j.cmi.2024.05.014_bib218","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/bjs.10309","article-title":"Randomized clinical trial of observational versus antibiotic treatment for a first episode of CT-proven uncomplicated acute diverticulitis","volume":"104","author":"Daniels","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.cmi.2024.05.014_bib219","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s41395-018-0030-y","article-title":"Long-Term effects of omitting antibiotics in uncomplicated acute diverticulitis","volume":"113","author":"van Dijk","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cmi.2024.05.014_bib220","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1463-1318.2011.02609.x","article-title":"Mild colonic diverticulitis can be treated without antibiotics. A case-control study","volume":"14","author":"de Korte","year":"2012","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib221","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/00365520600780650","article-title":"Conservative treatment of acute colonic diverticulitis: are antibiotics always mandatory?","volume":"42","author":"Hjern","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cmi.2024.05.014_bib222","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3109\/00365521.2014.968861","article-title":"No antibiotics in acute uncomplicated diverticulitis: does it work?","volume":"49","author":"Isacson","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cmi.2024.05.014_bib223","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.cgh.2020.03.049","article-title":"Antibiotics do not reduce length of hospital stay for uncomplicated diverticulitis in a pragmatic double-blind randomized trial","volume":"19","author":"Jaung","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cmi.2024.05.014_bib224","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00384-019-03343-w","article-title":"Prospective randomized clinical trial of uncomplicated right-sided colonic diverticulitis: antibiotics versus no antibiotics","volume":"34","author":"Kim","year":"2019","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib225","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ygh2.426","article-title":"Rifamycin vs placebo for the treatment of acute uncomplicated diverticulitis: a randomised, double-blind study","author":"Kruis","year":"2020","journal-title":"GastroHep"},{"key":"10.1016\/j.cmi.2024.05.014_bib226","first-page":"e435","article-title":"Efficacy and safety of nonantibiotic outpatient treatment in mild acute diverticulitis (DINAMO-study): a multicentre, randomised, open-label, noninferiority trial","volume":"274","author":"Mora-L\u00f3pez","year":"2021","journal-title":"Ann\u00a0Surg"},{"key":"10.1016\/j.cmi.2024.05.014_bib227","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/DCR.0000000000000579","article-title":"Symptomatic treatment for uncomplicated acute diverticulitis: a prospective cohort study","volume":"59","author":"Mali","year":"2016","journal-title":"Dis Colon\u00a0Rectum"},{"key":"10.1016\/j.cmi.2024.05.014_bib228","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10151-016-1464-0","article-title":"Selective non-antibiotic treatment in sigmoid diverticulitis: is it time to change the traditional approach?","volume":"20","author":"Estrada","year":"2016","journal-title":"Tech Coloproctol"},{"key":"10.1016\/j.cmi.2024.05.014_bib229","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00384-015-2258-y","article-title":"Outpatient, non-antibiotic management in acute uncomplicated diverticulitis: a prospective study","volume":"30","author":"Isacson","year":"2015","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib230","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1097\/DCR.0000000000001330","article-title":"Treatment of uncomplicated acute diverticulitis without antibiotics: a systematic review and meta-analysis","volume":"62","author":"Au","year":"2019","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.cmi.2024.05.014_bib231","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/DCR.0000000000001324","article-title":"Antibiotics versus No antibiotics for acute uncomplicated diverticulitis: a systematic review and meta-analysis","volume":"62","author":"Desai","year":"2019","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.cmi.2024.05.014_bib232","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/00365521.2018.1552987","article-title":"Acute uncomplicated diverticulitis managed without antibiotics - difficult to introduce a new treatment protocol but few complications","volume":"54","author":"Azhar","year":"2019","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cmi.2024.05.014_bib233","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.surge.2015.12.004","article-title":"A national evaluation of the management practices of acute diverticulitis","volume":"15","author":"Khan","year":"2017","journal-title":"Surgeon"},{"key":"10.1016\/j.cmi.2024.05.014_bib234","doi-asserted-by":"crossref","first-page":"e1126","DOI":"10.1093\/cid\/ciaa1831","article-title":"Impact of implementation of the core elements of outpatient antibiotic stewardship within veterans health administration emergency departments and primary care clinics on antibiotic prescribing and patient outcomes","volume":"73","author":"Madaras-Kelly","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.05.014_bib235","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.annemergmed.2007.03.022","article-title":"Cluster-randomized trial to improve antibiotic use for adults with acute respiratory infections treated in emergency departments","volume":"50","author":"Metlay","year":"2007","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib236","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1017\/ice.2019.295","article-title":"Impact of an electronic best-practice advisory in combination with prescriber education on antibiotic prescribing for ambulatory adults with acute, uncomplicated bronchitis within a large integrated health system","volume":"40","author":"Pagels","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2024.05.014_bib237","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-227X-13-7","article-title":"Over-prescribing of antibiotics and imaging in the management of uncomplicated URIs in emergency departments","volume":"13","author":"Xu","year":"2013","journal-title":"BMC Emerg Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib238","doi-asserted-by":"crossref","DOI":"10.1017\/ash.2022.316","article-title":"Characterizing barriers to antibiotic stewardship for skin and soft-tissue infections in the emergency department using a systems engineering framework","volume":"2","author":"Pulia","year":"2022","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"10.1016\/j.cmi.2024.05.014_bib239","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40545-019-0168-z","article-title":"Optimization of antibiotic selection in the emergency department for urine culture follow ups, a retrospective pre-post intervention study: clinical pharmacist efforts","volume":"12","author":"Almulhim","year":"2019","journal-title":"J Pharm Policy Pract"},{"key":"10.1016\/j.cmi.2024.05.014_bib240","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/0897190011420160","article-title":"Pharmacist-managed antimicrobial stewardship program for patients discharged from the emergency department","volume":"25","author":"Baker","year":"2012","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.cmi.2024.05.014_bib241","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.2146\/sp150036","article-title":"Pharmacist-driven antimicrobial optimization in the emergency department","volume":"73","author":"Davis","year":"2016","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.cmi.2024.05.014_bib242","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40121-014-0026-x","article-title":"Impact of a multidisciplinary culture follow-up program of antimicrobial therapy in the emergency department","volume":"3","author":"Dumkow","year":"2014","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.cmi.2024.05.014_bib243","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/0018578719844171","article-title":"Evaluation of antibiotic utilization in an emergency department after implementation of an antimicrobial stewardship pharmacist culture review service","volume":"55","author":"Giruzzi","year":"2020","journal-title":"Hosp Pharm"},{"key":"10.1016\/j.cmi.2024.05.014_bib244","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1093\/ajhp\/zxz335","article-title":"Privileging pharmacists improves time to patient notification in the microbiological test review process for patients discharged from the emergency department","volume":"77","author":"Loborec","year":"2020","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.cmi.2024.05.014_bib245","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.ajem.2014.07.033","article-title":"Pharmacist addition to the post-ED visit review of discharge antimicrobial regimens","volume":"32","author":"Miller","year":"2014","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib246","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1093\/ajhp\/zxaa064","article-title":"Involvement of pharmacist-reviewed urine cultures and sexually transmitted infections in the emergency department reduces time to antimicrobial optimization","volume":"77","author":"Olson","year":"2020","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.cmi.2024.05.014_bib247","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2146\/ajhp090552","article-title":"Effect of a pharmacist-managed culture review process on antimicrobial therapy in an emergency department","volume":"68","author":"Randolph","year":"2011","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.cmi.2024.05.014_bib248","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/87551225211000363","article-title":"Evaluating the addition of a clinical pharmacist service to a midlevel provider-driven culture follow-up program in a community emergency department","volume":"37","author":"Rainess","year":"2021","journal-title":"J Pharm Technol"},{"key":"10.1016\/j.cmi.2024.05.014_bib249","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1310\/hpj5109-738","article-title":"Evaluation of pharmacist impact on culture review process for patients discharged from the emergency department","volume":"51","author":"Santiago","year":"2016","journal-title":"Hosp Pharm"},{"key":"10.1016\/j.cmi.2024.05.014_bib250","article-title":"Pharmacist-Driven culture and sexually transmitted infection testing follow-up program in the emergency department","volume":"8","author":"Shealy","year":"2020","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.cmi.2024.05.014_bib251","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ajic.2019.07.018","article-title":"Outpatient antimicrobial stewardship: optimizing patient care via pharmacist led microbiology review","volume":"48","author":"Wattengel","year":"2020","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.cmi.2024.05.014_bib252","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s40121-017-0168-8","article-title":"Expanding antimicrobial stewardship to urgent care centers through a pharmacist-led culture follow-up program","volume":"6","author":"Dumkow","year":"2017","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.cmi.2024.05.014_bib253","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ajem.2016.12.036","article-title":"Urine culture guided antibiotic interventions: a pharmacist driven antimicrobial stewardship effort in the ED","volume":"35","author":"Zhang","year":"2017","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.cmi.2024.05.014_bib254","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/ajhp\/zxy023","article-title":"Pharmacist-led antimicrobial stewardship program in an urgent care setting","volume":"76","author":"Fay","year":"2019","journal-title":"Am J Health Syst Pharm"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24002519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24002519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T15:22:50Z","timestamp":1728919370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X24002519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":253,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1198743X24002519"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2024.05.014","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"European society of clinical microbiology and infectious diseases guidelines for antimicrobial stewardship in emergency departments (endorsed by European association of hospital pharmacists)","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2024.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}